Institutional investors purchased a net $576.3 thousand shares of ANTH during the quarter ended June 2017, and now own 37.35% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 373.0 Thousand shares of Anthera Pharmaceuticals I...